SIC 2835 – In Vitro and In Vivo Diagnostic Substances
| Valuation | |
|---|---|
| Market Cap ($M) | 1,027.65 |
| Enterprise Value ($M) | 838.47 |
| Book Value ($M) | 871.96 |
| Book Value / Share | 8.56 |
| Price / Book | 1.18 |
| NCAV ($M) | 320.80 |
| NCAV / Share | 3.15 |
| Price / NCAV | 3.20 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.48 |
| Return on Assets (ROA) | -0.40 |
| Return on Equity (ROE) | -0.49 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.77 |
| Current Ratio | 5.77 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 639.86 |
| Assets | 1,191.02 |
| Liabilities | 319.06 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 57.88 |
| Operating Income | -534.26 |
| Net Income | -519.02 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -348.88 |
| Cash from Investing | 125.57 |
| Cash from Financing | 185.75 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 10.00 | 22.07 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 624,750 | 2,680,988 | 23.30 | |
| 1,079,052 | 3,787,392 | 28.49 | |
| 938,296 | 3,366,690 | 27.87 | |
| 642,050 | 2,156,749 | 29.77 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NGNE – Neurogene Inc. | NKGN – NKGen Biotech, Inc. |
| NRIX – Nurix Therapeutics, Inc. | OCS – Oculis Holding AG |
| OCUL – Ocular Therapeutix, Inc. |
Financial data and stock pages provided by
Fintel.io